{
    "eid": "2-s2.0-84949496268",
    "title": "Effect of N- and T-type calcium channel blocker on proteinuria, blood pressure and kidney function in hypertensive patients: A meta-analysis",
    "cover-date": "2015-12-01",
    "subject-areas": [
        {
            "$": "Cardiology and Cardiovascular Medicine",
            "@code": "2705"
        },
        {
            "$": "Internal Medicine",
            "@code": "2724"
        },
        {
            "$": "Physiology",
            "@code": "1314"
        }
    ],
    "keywords": [
        "calcium channel blocker",
        "kidney function",
        "meta-analysis",
        "proteinuria"
    ],
    "authors": [
        "Natanong Thamcharoen"
    ],
    "citedby-count": 24,
    "ref-count": 61,
    "ref-list": [
        "Association between control to target blood pressures and healthy lifestyle factors among Japanese hypertensive patients: Longitudinal data analysis from Fukushima Research of Hypertension (FRESH)",
        "Causes of Death 2008: Data Sources and Methods",
        "A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010",
        "US renal data system 2010 annual data report",
        "2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)",
        "Efficacy and safety of combined vs. Single renin-angiotensin-aldosterone system blockade in chronic kidney disease: A meta-analysis",
        "2014 Evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8)",
        "Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity",
        "Albuminuria and Cardiovascular Risk in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study",
        "Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study",
        "Kidney disease: Improving global outcomes (KDIGO) blood pressure work group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease",
        "Add-on benefits of amlodipine and thiazide in nondiabetic chronic kidney disease stage 1/2 patients treated with valsartan",
        "Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients",
        "Effects of different ACE inhibitor combinations on albuminuria: Results of the GUARD study",
        "Powerful vascular protection by combining cilnidipine with valsartan in stroke-prone, spontaneously hypertensive rats",
        "Combination therapy for hypertension in patients with CKD: A subanalysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events trial",
        "Renal microcirculation and calcium channel subtypes",
        "T-type Ca channel blockers in patients with chronic kidney disease in clinical practice",
        "Assessing the quality of reports of randomized clinical trials: Is blinding necessary?",
        null,
        "Bias in meta-analysis detected by a simple, graphical test",
        "Comparison between valsartan and valsartan plus cilnidipine in type II diabetics with normo- and microalbuminuria",
        "Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease",
        "Combination therapy with renin-angiotensin system inhibitors and the calcium channel blocker azelnidipine decreases plasma inflammatory markers and urinary oxidative stress markers in patients with diabetic nephropathy",
        "Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy",
        "Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension",
        "Comparison of the antiproteinuric effects of the calcium channel blockers benidipine and amlodipine administered in combination with angiotensin receptor blockers to hypertensive patients with stage 3-5 chronic kidney disease",
        "Antiproteinuric effect of cilnidipine in hypertensive japanese treated with renin-angiotensin-system inhibitors-A multicenter, open, randomized trial using 24-hour urine collection",
        "Renoprotective effect of calcium channel blockers in combination with an angiotensin receptor blocker in elderly patients with hypertension. a randomized crossover trial between benidipine and amlodipine",
        "Comparative effects of benidipine and amlodipine on proteinuria, urinary 8-OHdG, urinary L-FABP, and inflammatory and atherosclerosis markers in early-stage chronic kidney disease",
        "Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria",
        "Urinary albumin excretion during angiotensin II receptor blockade: Comparison of combination treatment with a diuretic or a calcium-channel blocker",
        "Comparison of effects of azelnidipine and trichlormethiazide in combination with olmesartan on blood pressure and metabolic parameters in hypertensive type2 diabetic patients",
        "Switching to an L/N-type Calcium channel blocker shows renoprotective effects in patients with chronic kidney disease: The Kyoto cilnidipine study",
        "L/N-type calcium channel blocker cilnidipine added to renin-angiotensin inhibition improves ambulatory blood pressure profile and suppresses cardiac hypertrophy in hypertension with chronic kidney disease",
        "Comparison of the antialbuminuric effects of L-/N-type and L-type calcium channel blockers in hypertensive patients with diabetes and microalbuminuria: The study of assessment for kidney function by urinary microalbumin in randomized (SAKURA) trial",
        "L/N-type calcium channel blocker cilnidipine reduces plasma aldosterone, albuminuria, and urinary liver-type fatty acid binding protein in patients with chronic kidney disease",
        "Comparison of the antialbuminuric effects of benidipine and hydrochlorothiazide in renin-angiotensin system (RAS) Inhibitor-Treated Hypertensive Patients with Albuminuria: The COSMO-CKD (COmbination strategy on renal function of benidipine or diuretics treatment with ras inhibitors in a chronic kidney disease hypertensive population) study",
        "Revised Equations for Estimated GFR From Serum Creatinine in Japan",
        "Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease",
        null,
        null,
        "Differential expression of T- and L-type voltage-dependent calcium channels in renal resistance vessels",
        "Cilnidipine suppresses podocyte injury and proteinuria in metabolic syndrome rats: Possible involvement of N-type calcium channel in podocyte",
        "N-type calcium channel inhibition with cilnidipine elicits glomerular podocyte protection independent of sympathetic nerve inhibition",
        "Mechanistic view of renal protective action of calcium channel blockade",
        "L-/N-type calcium channel blockers and proteinuria",
        "Renal microcirculation and calcium channel subtypes",
        "Functional and pharmacological consequences of the distribution of voltage-gated calcium channels inthe renal blood vessels",
        "Global approach to cardiovascular risk in chronic kidney disease: Reality and opportunities for intervention",
        "The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population",
        "Hypertension Canada 2013",
        "[2010 Chinese guidelines for the management of hypertension].",
        "National Institute for Health and Care Excellence Hypertension: Clinical Management of Primary Hypertension in Adults (CG127",
        "Renoprotective and antioxidant effects of cilnidipine in hypertensive patients",
        "An investigation of the effect of advancing uraemia, renal replacement therapy and renal transplantation on blood pressure diurnal variability",
        "Thiazide diuretics enhance nocturnal blood pressure fall and reduce proteinuria in immunoglobulin A nephropathy treated with angiotensin II modulators",
        "Study of sustained blood pressure-lowering effect of azelnidipine guided by self-measured morning and evening home blood pressure: Subgroup analysis of the at-home study",
        "Efficacy of azelnidipine on home blood pressure and pulse rate in patients with essential hypertension: Comparison with amlopidine",
        "Effect of a novel calcium channel blocker on abnormal nocturnal blood pressure in hypertensive patients",
        "Azelnidipine decreases sympathetic nerve activity via antioxidant effect in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Boston",
            "affilname": "Caritas St. Elizabeth's Medical Center",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Boston",
            "affilname": "Tufts University School of Medicine",
            "affiliation-country": "United States"
        }
    ],
    "funding": []
}